Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: DVA

DaVita Inc.

Healthcare | Medical - Care Facilities
$234.91 +83.64 (+55.29%) as of 2026-07-14 17:17 UTC
Market Cap$15.1B
Volume696.2K
EPS (TTM)$9.84

DaVita Inc. (NYSE: DVA) is a $15.1B medical - care facilities company trading at $234.91 (+55.3% today) — 23.9× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-14 17:17 UTC.

52-Week Range
Low $143.07High $236.51

What DaVita Inc. does

DaVita Inc. is a healthcare company that provides kidney care services across multiple settings and stages of kidney disease. The company operates a U.S. dialysis business treating patients with end-stage kidney disease, international dialysis operations in multiple countries, and a U.S. integrated kidney care business that manages patients under risk-based arrangements. DaVita's care model emphasizes patient choice and comprehensive kidney services, supported by clinical teams including nephrologists, nurses, dietitians, and other healthcare professionals.

Summarized from DaVita Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$234.91
Change (1D)+83.64 (+55.29%)
Market cap$15.1B
Volume696.2K shares
52-week range$143.07 – $236.51
Valuation
P/E (TTM)23.87×
EV/EBITDA5.20×
EPS (TTM)$9.84
Return on equity-114.70%
Returns
52-week return+64.2%
Revenue, margins & earnings
FY2021 Net income: $978MFY2021 Taxes & interest: $819MFY2021 Operating costs: $9.82B$11.6BFY2021FY2022 Net income: $560MFY2022 Taxes & interest: $779MFY2022 Operating costs: $10.3B$11.6BFY2022FY2023 Net income: $692MFY2023 Taxes & interest: $911MFY2023 Operating costs: $10.5B$12.1BFY2023FY2024 Net income: $936MFY2024 Taxes & interest: $1.15BFY2024 Operating costs: $10.7B$12.8BFY2024FY2025 Net income: $747MFY2025 Taxes & interest: $1.30BFY2025 Operating costs: $11.6B$13.6BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-17
  • 2026-06-17Waters Kathleen AlyceChief Legal & Pub. Affairs OffSELL-6,455$1.35M
  • 2026-06-17Waters Kathleen AlyceChief Legal & Pub. Affairs OffSELL-8,950$1.86M
  • 2026-06-17Rodriguez JavierChief Executive OfficerSELL-30,000$6.29M
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • BERKSHIRE HATHAWAY INC30,100,585$4.63B-5.2%
  • VANGUARD GROUP INC3,834,095$435.59M-9.3%
  • VANGUARD CAPITAL MANAGEMENT LLC2,180,225$335.08MNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does DaVita Inc. do?

DaVita Inc. is a medical - care facilities company, listed on NYSE as DVA.

What is DVA's valuation?

DVA trades at $234.91, 23.87× trailing earnings, 5.20× EV/EBITDA, as of 2026-07-14.

When did DVA last file with the SEC?

DaVita Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-08. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 17:17 UTC. This page is also available as JSON at /api/data?ticker=DVA and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for DVA and 3,500+ tickers.

Create a free account — keep DVA
For your agent
GET /api/data?ticker=DVA

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt